Quick Answer
SINOVAC BIOTECH LTD reported Operating Income of -$603.02 million for fiscal year 2023.
SINOVAC BIOTECH LTD Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2023 | -$603.02M | -29.4% |
| 2022 | -$466.07M | -102.7% |
| 2021 | $17.55B | +8039.9% |
| 2020 | $215.64M | +214.5% |
| 2019 | $68.56M | +51.3% |
| 2018 | $45.32M | -0.2% |
| 2017 | $45.42M | +8911.3% |
| 2016 | $504.0K | -86.4% |
| 2015 | $3.69M | +96.0% |
| 2014 | $1.89M | -81.0% |
| 2013 | $9.95M | +147.0% |
| 2012 | -$21.15M | -726.9% |
| 2011 | $3.37M | +127.8% |
| 2010 | -$12.12M | -128.8% |
| 2009 | $42.15M | — |
- SINOVAC BIOTECH LTD showed a decrease of -29.4% in Operating Income compared to the prior fiscal year.
- Over the 2009–2023 period, SINOVAC BIOTECH LTD’s operating income has declined by 1530.7% (from $42.15 million to -$603.02 million).
- The most recent figure is from SINOVAC BIOTECH LTD’s fiscal year 2023 report (Form 20-F), filed with the SEC on April 29, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: